Protests erupt in India after an Italian factory linked to cancer-causing Pfas chemicals was dismantled, sold to Indian company Laxmi Organic Industries, and rebuilt near Mumbai, highlighting India's lack of Pfas regulations.
Reliance Industries Limited has made history by becoming the first Indian company to achieve over $120 billion in revenue for FY 2025-26, reporting $124 billion. This milestone follows their recent achievement of crossing $10 billion in annual net profit.
Sun Pharma, India's largest pharma company, has acquired US-listed Organon & Co for $11.8 billion (Rs 98,000 crore) in an all-cash transaction — the biggest-ever overseas pharma deal by an Indian company. Sun Pharma will pay $14 per share, a 24% premium to Organon's closing price. The acquisition adds over 140 high-growth markets including China, and portfolio of women's health, biosimilars, and legacy brands. Once completed, it will double Sun Pharma's revenue to $12.4 billion and EBITDA to $3.7 billion, ranking it among top 25 global pharmaceutical companies.
Reliance Industries achieved a record net profit of Rs 95,610 crore in FY26, becoming the first Indian company to surpass $10 billion in annual profit. The Mukesh Ambani-led conglomerate posted an 18% YoY rise in profit after tax, though Q4 saw a 12.6% decline due to weakness in the oil-to-chemicals segment. Consumer businesses Jio and Reliance Retail continued robust growth with retail crossing 20,000 stores.
